Jan 03, 2018 21:05 pm UTC| Business
TEL AVIV, ISRAEL, Jan. 03, 2018 -- InspireMD, Inc. (NYSE AMER: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that it will host a...
Jan 03, 2018 21:05 pm UTC| Business
IRVINE, Calif., Jan. 03, 2018 -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that Fitch Ratings issued a Spotlight Series report on December 21, 2017 highlighting Sabra’s BBB- rating that...
Jan 03, 2018 21:05 pm UTC| Business
CAMBRIDGE, Mass., HERTFORDSHIRE, United Kingdom and PITTSBURGH, Jan. 03, 2018 -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) and Mylan N.V. (NASDAQ:MYL) (TASE:MYL) today announced the development strategy for M710, a...
BBSI to Present at CJS Securities’ 18th Annual “New Ideas” for the New Year Conference
Jan 03, 2018 21:05 pm UTC| Business
VANCOUVER, Wash., Jan. 03, 2018 -- Barrett Business Services, Inc. (BBSI) (NASDAQ:BBSI), a leading provider of business management solutions, will present at the CJS Securities’ 18th Annual “New Ideas” for the New Year...
Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference
Jan 03, 2018 21:05 pm UTC| Business
DUBLIN, Ireland, Jan. 03, 2018 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience...
Landec Corporation Reports Second Quarter and First Half Fiscal 2018 Results
Jan 03, 2018 21:04 pm UTC| Business
Second Quarter Meets Revenue Expectations and Revised Net Income Expectations Company Reiterates Full Year Fiscal 2018 Guidance SANTA CLARA, Calif., Jan. 03, 2018 -- Landec Corporation (NASDAQ:LNDC), a leading...
Achaogen to Present at J.P. Morgan Healthcare Conference
Jan 03, 2018 21:01 pm UTC| Business
– Company presentation scheduled for January 11, 2018 – SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials...